CAPR Capricor Therapeutics

Watchlist

15.950
+0.400+2.57%

Close Feb 14 16:00 ET

725.25MMarket Cap-15.64P/E (TTM)

About Capricor Therapeutics Company

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Company Profile

SymbolCAPR

Company NameCapricor Therapeutics

Listing DateMar 9, 2015

Founded1996

CEODr. Linda Marban, PhD

MarketNASDAQ

Employees102

Fiscal Year Ends12-31

Address10865 Road to the Cure,Suite 150

CitySan Diego

ProvinceCalifornia

CountryUnited States of America

Zip Code92121

Phone1-858-727-1755

Websitehttp://www.capricor.com

Company Executives

Name
Position
Salary

Dr. Linda Marban, PhD
President, Chief Executive Officer and Director
747.32K

Anthony J. Bergmann, M.B.A.
Principal Accounting Officer, Chief Financial Officer and Corporate Treasurer
730.85K

Karen G. Krasney, J.D.
Executive Vice President, General Counsel and Secretary
740.77K

Dr. Frank Litvack,M.D.
Executive Chairman of the Board
759.55K

Michael Kelliher
Independent Director
681.38K

David B. Musket
Independent Director
237.36K

Dr. Philip J. Gotwals, PhD
Independent Director
467.36K

George W. Dunbar,Jr
Independent Director
211.13K

Karimah Es Sabar
Independent Director
196.14K

Earl M. Collier, Jr
Independent Director
222.37K

Dr. Paul Gisbert Auwaerter, M.B.A.,M.D.
Independent Director
459.43K

CAPR Capricor Therapeutics

About Capricor Therapeutics Company

Company Profile

Company Executives

Trending Stocks